# Compass Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Aug 18, 2025

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: SCHEDULE 13D/A
- Filed: 2025-08-18
- Accepted by EDGAR: Aug 18, 2025, 22:35 ET
- Period: not reported
- Accession: 0000950170-25-109869
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000095017025109869/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000095017025109869/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000095017025109869/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Aug 18, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-109869. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.